Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M MacDonald

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Journal of Cardiovascular Pharmacology|June 21, 2006
A European's perspective of COX-2 drug safetyThomas M MacDonald
Basic & Clinical Pharmacology & Toxicology|April 14, 2006
Is there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen?Thomas M MacDonald, Li Wei
Clinical Endocrinology|September 27, 2003
Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertensionPitt O Lim, Thomas M MacDonald
Expert Opinion on Pharmacotherapy|February 28, 2002
Gastrointestinal side effects of NSAIDs - pharmacoeconomic implicationsChristopher L Sheen, Thomas M MacDonald
Current Hypertension Reports|March 17, 2007
Mineralocorticoid receptor antagonistsHari Krishnan Parthasarathy, Thomas M MacDonald
Expert Opinion on Pharmacotherapy|January 12, 2010
Treatment of osteoarthritis in hypertensive patientsIsla S Mackenzie, Thomas M MacDonald
British Journal of Clinical Pharmacology|November 28, 2018
Identifying poor adherence to antihypertensive medications in patients with resistant hypertensionIsla S Mackenzie, Thomas M MacDonald
Journal of the American Heart Association|October 30, 2018
Reaching an ACCORD on Glycemia and Systolic Blood Pressure Targets in Type 2 Diabetes MellitusThomas M MacDonald, Isla S Mackenzie
British Journal of Clinical Pharmacology|February 19, 2008
Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United KingdomThomas M MacDonald, Steven V Morant
Cardiovascular Research|February 27, 2004
Review of aldosterone- and angiotensin II-induced target organ damage and preventionAllan D Struthers, Thomas M MacDonald
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Journal of Cardiovascular Pharmacology|June 21, 2006
A European's perspective of COX-2 drug safetyThomas M MacDonald
Basic & Clinical Pharmacology & Toxicology|April 14, 2006
Is there an interaction between the cardiovascular protective effects of low-dose aspirin and ibuprofen?Thomas M MacDonald, Li Wei
Clinical Endocrinology|September 27, 2003
Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertensionPitt O Lim, Thomas M MacDonald
Expert Opinion on Pharmacotherapy|February 28, 2002
Gastrointestinal side effects of NSAIDs - pharmacoeconomic implicationsChristopher L Sheen, Thomas M MacDonald
Current Hypertension Reports|March 17, 2007
Mineralocorticoid receptor antagonistsHari Krishnan Parthasarathy, Thomas M MacDonald
Expert Opinion on Pharmacotherapy|January 12, 2010
Treatment of osteoarthritis in hypertensive patientsIsla S Mackenzie, Thomas M MacDonald
British Journal of Clinical Pharmacology|November 28, 2018
Identifying poor adherence to antihypertensive medications in patients with resistant hypertensionIsla S Mackenzie, Thomas M MacDonald
Journal of the American Heart Association|October 30, 2018
Reaching an ACCORD on Glycemia and Systolic Blood Pressure Targets in Type 2 Diabetes MellitusThomas M MacDonald, Isla S Mackenzie
British Journal of Clinical Pharmacology|February 19, 2008
Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United KingdomThomas M MacDonald, Steven V Morant
Cardiovascular Research|February 27, 2004
Review of aldosterone- and angiotensin II-induced target organ damage and preventionAllan D Struthers, Thomas M MacDonald
Pageof 16